Point of Care Rapid STI Test Optimization and Validation Extension

Completed

• Conditions: Chlamydia Trachomatis Genital Infection; Gonorrhea; Trichomoniasis

• Registration Number: NCT06566677
• Lead Sponsor: Wits RHI Research Centre Clinical Research Site

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-16
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br>Participants must meet the following criteria to be eligible for inclusion in the study:<br><br> - Cisgender adolescent girls and young women (18-25 years of age, inclusive), screened<br> for or enrolled in the ARISE study.<br><br> - Willing to provide written informed consent to participate in this sub-study.<br><br> - Willing to provide additional samples including vaginal and endocervical swabs,<br> urine and those collected through the use of tampons and disposable menstrual cups.<br><br>Exclusion Criteria:<br><br> - Cisgender male or transgender woman or transgender man<br><br> - Age <18 years<br><br> - Unable or unwilling to provide written informed consent<br><br> - Have any condition that in the opinion of the investigators will interfere with<br> successful completion of sub-study procedures

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GeneXpert

Secondary Outcome Measures

Name	Time	Method
Osom rapid testing kit